SCHEMBL6857527

SCHEMBL6857527

C=C1C(=N)NC(=O)N1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24816427 0.73
SCHEMBL9679520 0.70
SCHEMBL9677675 0.70
SCHEMBL16705492 0.67 CRBN (0.32)
SCHEMBL9678809 0.67
SCHEMBL13705533 0.65
SCHEMBL9678649 0.63 CYP3A4 (0.41)
SCHEMBL15624085 0.62
SCHEMBL13995655 0.60 MAPT (0.39)
SCHEMBL10178063 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011016501-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER 武田薬品工業株式会社 (JP) 2011-02-10 WO disclosed
EP-0373542-B1 IMIDAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Roche Diagnostics GmbH (DE) 1992-06-17 EP disclosed
US-4996219-A Antibody inhibitors BOEHRINGER MANNHEIM GMBH (DE) 1991-02-26 US disclosed
EP-0373542-A1 Imidazoline derivatives, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1990-06-20 EP disclosed